Zydus Therapeutics
Zydus Therapeutics is seeking a Director, Field & Market Access Data Analytics to serve as a strategic analytics partner supporting customer-facing teams for the anticipated US launch of saroglitazar. This role involves delivering actionable insights, performance analytics, and data-driven recommendations to enable field execution excellence and market access success. The position requires leveraging key healthcare data assets to support analytical needs across field sales, key account management, and thought leader liaison teams.
Headquarters
Pennington, New Jersey, United States
Zydus Therapeutics is a clinical-stage, specialty-focused biopharmaceutical company dedicated to developing transformative treatments for rare and serious liver diseases. As a subsidiary of Zydus Lifesciences, the company leverages a research team of 1,300 scientists and is currently enrolling patients in two late-stage clinical trials, including studies on Primary Biliary Cholangitis (PBC) and NASH. Its pipeline includes Saroglitazar Mg, which has received FDA Fast Track Designation for PBC treatment.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Zydus Therapeutics.
Director, Market Access Analytics
Regeneron Pharmaceuticals
Analyst, Market Access Analytics
Bristol Myers Squibb
Executive Director, US Portfolio Analytics
Revolution Medicines
Director, Market Access Analytics
Revolution Medicines
Director, Market Access Deal Analytics
Axsome Therapeutics
Senior Analyst, Market Access Analytics
Bristol Myers Squibb